The MHRA has five top tips to help you stay well through the festive season and beyond
Similar Posts
Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, EL(25)A/42
Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.
Apply for a licence to market a medicine in the UK
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
Device specific vigilance guidance: Cardiac Implantable Electronic Devices (CIEDs)
Guidance for manufacturers of cardiac implantable electronic devices and their leads. It outlines specific scenarios that should be considered when determining if an incident is reportable.
MHRA Safety Roundup: May 2025
Summary of the latest safety advice for medicines and medical device users
Regulation of AI in Healthcare
The MHRA is seeking evidence on the regulation of AI in healthcare to inform the recommendations of the National Commission into the Regulation of AI in Healthcare.
Submission and assessment timetables for innovative medicines applications
Guidance on the deadlines for initial and response submissions.
